Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Mekong-Plus Programme Review Group

Chairman
Prof Dato C P Ramachandran
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
Serdang
Malaysia

Tel: +60 3 948 6101/ +60 3 298 7275
F ax: +603 2698 6152
e-mail: ramacp@hotmail.com

WHO Focal Point
Dr. John Ehrenberg
Regional Advisor/MVP
WHO - WPRO
Manila
Philippines

Tel: +632 528 9725
F ax: +632 52 11 036
e-mail: ehrenbergj@wpro.who.int


Dr. Chusak Prassitisuk
Regional Advisor-Vector Borne Diseases Control
and Regional Focal Point for Leprosy Elimination
WHO - SEARO
World Health House
Indraprastha Estate
New Delhi 110002
India

Tel: +91 11 233 70804 Ext: 26117
Fax: +91 11 233 78412
e-mail: chusakp@searo.who.int

A Social Mobilization and Training team from WHO headquarters, Geneva, has been assisting countries such as the Philippines by providing COMBI (Communication-for-Behavioural-Impact) training with national support. The outcome will be a complete door-to-door mass drug administration (MDA) campaign in several provinces that will be used as a model for further scaling-up next year.

National programme managers agree that, despite substantial efforts, current funding gaps will hamper full implementation of lymphatic filariasis elimination activities. However, innovative fund-raising activities are under way. For example, the Japanese government will fund Health Fairs in 2003, at which immunization will be offered to rural populations; it is hoped that this will become a model of synergy with other programmes. The Fairs will be limited to appropriate areas, however, and nationwide door-to-door MDAs will become the norm. The Chair of the Mekong Plus PRG reports that Member States have achieved coverage of about 17% of the at-risk population of 210 million.

 

 

© Global Alliance to Eliminate Lymphatic Filariasis